26 May 2013
Keywords: ph, iib, data, alizyme, atl-962, suggest, breakthrough
Article | 29 September 2003
The potentially massive but still relatively poorly-served market for the treatment of obesity could get a boost in the next ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 September 2003
24 May 2013
© 2013 thepharmaletter.com